Antimicrobial Agents and Catheter Complications in Outpatient Parenteral Antimicrobial Therapy
- PMID: 29493791
- PMCID: PMC5902416
- DOI: 10.1002/phar.2099
Antimicrobial Agents and Catheter Complications in Outpatient Parenteral Antimicrobial Therapy
Abstract
Objectives: Debate about whether certain antimicrobial agents traditionally considered vesicants increase the risk of catheter complications has led to uncertainty in venous catheter placement protocols. To understand whether patients requiring home-based outpatient parenteral antimicrobial therapy (OPAT) should receive peripheral catheters (e.g., midline catheters) versus central venous catheters, and to understand whether certain antimicrobial agents place home-based OPAT patients at higher risk for catheter complications, we investigated associations between antimicrobial agent(s) and catheter complications.
Methods: We performed a prospective cohort study of patients requiring home-based OPAT discharged from two urban tertiary care academic medical centers, including telephone surveys and chart abstractions. Multivariable Poisson regressions were used to evaluate: (i) associations between antimicrobial agents traditionally considered vesicants, based on pH or osmolarity, and catheter complication rates, and (ii) associations between antimicrobial agent and rates of catheter complications.
Results: Vesicant antimicrobials defined using pH or osmolarity criteria were not associated with an increased rate of catheter complications (adjusted incidence rate ratio [aIRR]: 1.63, 95% confidence interval [CI]: 0.89-2.96). Vancomycin was associated with an increased rate of catheter complications, as was daptomycin (aIRR: 2.32 [95% CI: 1.20-4.46] and 4.45 [95% CI: 1.02-19.41], respectively). Staphylococcus aureus infections were also associated with an increased rate of catheter complications (aIRR: 2.13, 95% CI: 1.09-4.19), as were midline catheters (aIRR: 9.44, 95% CI: 2.12-41.97).
Conclusions: Our study supports recent guidance identifying vancomycin as a vesicant, among a subset of antimicrobial agents, and removal of pH criteria for identification of vesicants.
Keywords: OPAT; antimicrobial therapy; catheter complications; parenteral antibiotics; venous catheter; vesicant.
© 2018 Pharmacotherapy Publications, Inc.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
The authors have no conflicts of interest to declare.
References
-
- Nathwani D, Tice A. Ambulatory antimicrobial use: the value of an outcomes registry. J Antimicrob Chemother. 2002;49(1):149–54. - PubMed
-
- Gorski LA, Stranz M, Cook LS, et al. Development of an evidence-based list of noncytotoxic vesicant medications and solutions. J Infus Nurs. 2017;40(1):26–40. - PubMed
-
- Trissel LA. Handbook on Injectable Drugs. 11. Bethesda, MD: ASHP; 2001.
-
- Gorski LA. The 2016 infusion therapy standards of practice. Home Healthc Now. 2017;35(1):10–8. - PubMed
-
- Gorski LA, Hadaway L, Hagle M, McGoldrick M, Orr M, Doellman D. The 2016 infusion therapy standards of practice. J Infus Nurs. 2016;39(1S):S1–S159. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
